HCRT and synucleinopathy: Orexin has been argued to play a neuroprotective and immune-regulatory role in the central nervous system, which may be affected in later stages of alpha-synucleinopathy process, when alpha-synuclein may act to promote the degradation of OX1R through lysosomal and proteasomal pathways [30, 96].